Actriib-mfc

Actriib-mfc has been studied in 1 paper since 2011: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Feb 1, 2011: “Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice”.

Intervention

1 paper studies it3 findingsUpdated

See all 1 papers on actriib-mfc

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Joshua Frase Foundation and 2 more
  • 3 of 3 findings with company ties
  • Animals1

What did studies of actriib-mfc find?

3

Studies of actriib-mfc measured 3 outcomes: type 2b myofiber hypertrophy, forelimb grip strength and lifespan.

Type 2b myofiber hypertrophy

upin mice1

1 study
  1. Actriib-mfc increases type 2b myofiber hypertrophy in mice (restricted to type 2b myofibers).

    “ActRIIB-mFC produced marked hypertrophy restricted to type 2b myofibers”

    Animalsrestricted to type 2b myofibersskeletal muscle

    Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice

    The American journal of pathology

Forelimb grip strength

upin mice1

1 study
  1. Actriib-mfc increases forelimb grip strength in mice (transient increase during treatment of Mtm1δ4 mice).

    “with transient increases in weight, forelimb grip strength, and myofiber size”

    Animalstransient increase during treatment of Mtm1δ4 mice

    Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice

    The American journal of pathology

Lifespan

upin mice1+17% extension

1 study
  1. Actriib-mfc extends lifespan in myotubularin-deficient Mtm1δ4 mice (17% extension).

    “Treatment of Mtm1δ4 mice with ActRIIB-mFC produced a 17% extension of lifespan”

    Animalsin myotubularin-deficient Mtm1δ4 mice

    Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice

    The American journal of pathology

Latest